Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5530 Wisconsin Ave
Ste 1150
Chevy Chase, MD 20815Phone+1 301-656-7374Fax+1 301-656-1019- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1993 - 1996
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1991
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1990
- University of California (San Francisco)Residency, Internal Medicine, 1983 - 1986
- University of Miami Leonard M. Miller School of MedicineClass of 1983
Certifications & Licensure
- CA State Medical License 1985 - Present
- MD State Medical License 1991 - 2024
- DC State Medical License 1991 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification RcopiaMU EHR, DrFirst.com, Inc., 2011-2013
Publications & Presentations
PubMed
- Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.Kefang Lai, Dejun Sun, Ranran Dai, Ronnie Samoro, Hae-Sim Park, Annika Åstrand, David Cohen, Maria Jison, Vivian H Shih, Viktoria Werkström, Yuhui Yao, Yajuan Zhang, W...> ;Respiratory Medicine. 2024 Apr 1
- 4 citationsReduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-...David J Jackson, Liam G Heaney, Marc Humbert, Brian D Kent, Anat Shavit, Lina Hiljemark, Lynda Olinger, David Cohen, Andrew Menzies-Gow, Stephanie Korn> ;Lancet. 2024 Jan 20
- 83 citationsEffect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a mu...Richard J. Russell, Latifa Chachi, J. Mark FitzGerald, Vibeke Backer, Ronald Olivenstein, Ingrid Louise Titlestad, Charlotte Suppli Ulrik, Tim Harrison, Dave Singh, Re...> ;The Lancet. Respiratory Medicine. 2018 Jul 1
Professional Memberships
- Member
Hospital Affiliations
- Sibley Memorial HospitalWashington, District of Columbia
- Suburban HospitalBethesda, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: